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Increased oxidative stress has important molecular, struc-
tural, and functional muscle implications. In pathological
conditions, reactive oxygen species (ROS) burst contributes
to cellular dysfunction and the progression of muscle dis-
eases. This special issue was designed to advance knowledge
in the role of oxidative stress on muscle remodeling, in turn
leading to innovative therapeutic approaches in a wide range
of muscle diseases. Therefore, this special issue provides
recent scientific advancements with researchers and practi-
tioners who work in muscle scope. Articles included in this
special issue address the molecular and cellular mechanisms
involved in these processes as well as current therapies.
One of the studies published in the special issue exam-
ined the impact of 8-week dynamic resistance training
with elastic bands on oxidative stress in stroke survivors.
Functional fitness, hemodynamic, and cardiac autonomic
modulation were also evaluated. The exercise protocol
consisted of a sequence of three combinations of two con-
secutive exercises (i.e., seated row and squat on the chair,
vertical chest press and squat on the chair, and knee
extension and squat on the chair) in a dynamic manner,
without intervals of absolute rest throughout the session.
Exercise volume was increased over the 8-week protocol,
in which three sets of 6-8 repetitions at moderate intensity
(3 to 5 points on Borg scale) were performed in the first
four weeks and three sets of 10-12 repetitions at moderate
intensity were performed in subsequent weeks. The main
findings were a plasma reduction in the levels of thiobar-
bituric acid reactive substances (TBARS) and carbonyls
and an increased activity of superoxide dismutase (SOD).
Exercised patients also showed improvements in functional
fitness and sympathovagal balance. Therefore, the study
has addressed the importance of resistance training using
simple equipment such as elastic bands to reduce oxidative
stress and improve cardiac autonomic control and func-
tionality in chronic stroke survivors.
Excessive oxidative stress has been stimulated by exer-
cise. The increase in ROS can be dependent on the type,
duration, and load of the exercise [1]. ROS at low levels, a
phenomenon similar to hormesis, plays an important role
in exercise-induced physiological adaptation [2]. However,
excessive oxidative stress can result in impaired physical per-
formance and maladaptive skeletal muscle recovery [3].
Recently, experimental studies in rodents have indicated that
photobiomodulation (PBM) could be a new alternative to
modulate the excessive oxidative stress induced by exercise
[4–10]. Several positive findings were highlighted, including
(i) lower damage, inflammation, and lipoperoxidation of
muscle; (ii) increased activity of antioxidant enzymes; and
(iii) delayed muscle fatigue. On a translational perspective
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of these findings, in this special issue has included a random-
ized, triple-blind, placebo-controlled crossover trial con-
ducted by S. S. Tomazoni et al. The authors applied PBM
(using infrared low-level laser therapy; a total of 850 J of
energy) before a high-intensity progressive running test until
exhaustion in soccer players. The PBM application brought
about improvements in rates of oxygen uptake and time
until exhaustion. Moreover, PBM showed to decrease mus-
cle damage, interleukin 6 (IL-6), TBARS, and carbonylated
protein levels. On the other hand, PBM led to increased
activity of SOD and catalase (CAT) enzymes. Thus, PBM
could be a promising approach to improve physical perfor-
mance and to counter damage, inflammation, and oxida-
tive stress associated with running high-intensity exercise.
Further studies are needed to understand the influence of
different irradiation dosages and whether the effects pub-
lished by S. S. Tomazoni et al. can exist in distinct types
of exercises.
Several studies support the existence of an interdepen-
dent relationship between inflammation and oxidative stress
[11, 12]. Among factors playing a key role in skeletal muscle
pathophysiology and potentially linking inflammation and
oxidative stress, IL-6 is a possible candidate [13]. In this
regard, L. Forcina et al. tried to investigate whether elevated
circulating levels of the IL-6 could disturb the redox balance
in skeletal muscle, independent of tissue damage and inflam-
matory response. Using NSE/IL-6 transgenic mice character-
ized by systemically elevated levels of IL-6, the authors show
enhanced ROS production and accumulation in the dia-
phragm muscle. Alteration of the IL-6-linked homeostasis
redox appears to require a complex network of interactions
that involve the regulation of hydrogen peroxide, nicotin-
amide adenine dinucleotide phosphate-dependent superox-
ide scavengention, and mitochondrial antioxidant defense.
This special issue also covers the role of ROS played in the
development of cell death and cardiovascular diseases. The
review article of T. Xu et al. also explored the potential
application of the anti-ROS approach in the treatment of car-
diovascular diseases. First, the authors documented the dif-
ferent ROS sources and the role of ROS accumulation in
vascular dysfunction and cardiac remodeling. Second, the
proposal was to address the repercussion of excessive ROS
production in the induction of cell death. It has been regis-
tered as ROS is closely related to cardiomyocyte apoptosis,
autophagy, ferroptosis, and necrosis. Third, the authors
reviewed important aspects for several antioxidant agents,
including tripeptide glutathione, SOD, CAT, thioredoxin,
oxidative stress response transcription factors (e.g., AP-1,
HSF1, Nrf2, and FOXO3a), N-acetylcysteine, vitamin E,
and NAD+. The last concerns were targeted to clinical trials
that evaluated the impact of inhibiting oxidative stress in car-
diovascular diseases, in which they have failed to mitigate
cardiac remodeling and the evolution of heart failure.
Kynurenine (KYN) is a circulating tryptophan metabolite
that increases with age and is implicated in several age-
related disorders [14]. In this regard, H. Kaiser et al. hypoth-
esized that an increase in KYNwith age contributes to muscle
atrophy and oxidative stress. In vitro experiments showed
that KYN treatment of mouse and human myoblasts
increased levels of ROS. Young mice had higher muscle lipid
peroxidation and reduced muscle size and strength in
response to KYN treatment. Aged mice treated with indo-
leamine 2,3-dioxygenase inhibitor, an enzyme involved in
the generation of KYN, showed an increase in muscle fiber
size and muscle strength. Protein expression assays revealed
very long-chain acyl-CoA dehydrogenase as a factor
activated by KYN that may increase ROS and lipid peroxi-
dation. Collectively, these findings make it possible to con-
sider KYN involvement in sarcopenia with age. It appears
that the deleterious effects of chronic KYN exposure are
mediated by increased oxidative stress. V. Cenni et al. pre-
sented an interesting review that describes the effects of the
Ankrd2 modulation stimulate by mechanotransduction and
cellular ROS. Moreover, they demonstrated a possible rela-
tion with the pathogenesis of muscular laminopathies. First,
the authors documented the Ankrd2 in striated muscles
focusing on expression in skeletal and cardiac muscles, as
well as, mechanotransduction in skeletal muscle. They
demonstrated how physical exercise could stimulate an
Ankrd2 upregulation from oxidative and mechanical
stresses. Second, they proposed pathogenic mechanisms in
which Ankrd2 might be involved. Third, it showed the per-
spectives of the study of Lamin-AAnkrd2 interplay, specifi-
cally the mechanosignaling through Ankdr2 and therapeutic
perspectives. It is important to highlight that the authors
showed illustrations for the complex network that involve
the relation between Ankrd2 and pathogenesis of muscular
laminopathies.
Another interesting study was carried out by S. Q.
Rodríguez-Lara et al. which showed a pharmacological
approach to reduce ischemia-reperfusion (I/R) damage. This
phenomenon can be induced by cellular ROS, resulting in
deleterious effects on the lesion, and there is no pharmaco-
logical approach to avoid or decrease these dangerous effects.
However, the authors presented Telmisartan as a possible
pharmacological approach because it seems to affect the con-
centration and activity of enzymatic scavengers, which could
decrease lesion development. For this, male Wistar rats were
submitted to treatment with Telmisartan for seven days
before I/R lesion and then were evaluated at 1 h, 24 h, 72 h,
7, and 14 days following reperfusion. Muscle samples were
obtained to determine SOD-2 and CAT gene expression.
The biochemical assay was used to determine the oxidative
and antioxidative markers. Histological tissue evaluation
from the right gastrocnemius muscle was performed. The
main results were that the approach of Telmisartan (i) pro-
duced changes in the SOD-2 and CAT gene expression
regarding reperfusion, (ii) reduced oxidative markers levels
in the local tissue, and (iii) promoted injury attenuation
between 24h and 14 days. A novel pharmacological approach
with Telmisartan demonstrated to be promissory to reduce
damages during I/R damage. The elderly population has been
increasing, and sarcopenia became a vital topic to be studied
because it affects autonomy in daily life and compromises the
quality of life [15]. In this issue, N. Z. Azlan et al. described
several strategies to counter sarcopenia and among them pre-
sented the Chlorella vulgaris, a green alga that seems to pro-
mote muscle regeneration. The authors aimed to establish
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the effects of the differentiation of myoblast cells during the
formation of mature myotubes in culture. For this, human
myoblast cells were obtained from young men and women
and then were cultured on adequate conditions and stimu-
lates until reaching senescence. Cells were treated with Chlo-
rella vulgaris and incubated for up to seven days to induce
differentiation. Different techniques were used to analyze
the ability of Chlorella vulgaris to promote myoblast differ-
entiation (e.g., cellularmorphology, real-timemonitoring, cell
proliferation, senescence-associated B-galactosidase expres-
sion, myogenic differentiation, myogenic expression, and
cell cycle profiling). Chlorella vulgaris improved the regen-
erative capacity of young and senescent myoblasts,
stimulating differentiation, demonstrating to have a high
potential to treat sarcopenia.
K. P. Dzik et al. show in this issue the relations among
muscle atrophy and vitamin D deficiency. The authors
describe the muscle function affected by vitamin D defi-
ciency and the development of muscle atrophy. Lumbar
back pain (LBP) patients showed paravertebral muscle atro-
phy. The authors investigated muscle atrophy markers, sig-
naling proteins, and mitochondrial capacity in LBP patients
according to sex and vitamin D levels. Men and women
were distributed into three groups according to levels of
vitamin D received for five weeks. Three dosages of vitamin
D were established to reach deficiency, normal, and above
normal levels. The key results were that the vitamin D
deficiency-induced stress oxidative, which is involved in a
cascade of enzymatic events that leads to muscle atrophy
and mitochondrial dysfunction, is most present in women
due to higher Atrogin-1 levels. Normal or higher levels of
vitamin D increase the mitochondrial function and inhibit
muscle atrophy.
C. D. Pandya et al. described the role of oxidative stress
on aging and their mechanisms that results in sarcopenia
and osteoporosis. They empathize the possible effects of reg-
ulation of arginase from oxidative stress on the survival and
differentiation of myoblasts. The authors aimed to investigate
the arginase activity and expression in the skeletal muscle in
young and aged mice. First, arginase activity and arginase 1
expression were determined. Second, the expression of oxi-
dative stress-related signaling molecules in muscles of aged
mice was performed. Third, in vitro studies were conducted
with myoblast cell line (C2C12) and arginase inhibitor
(ABH). The main results were an elevated arginase activity
in aged muscle and a reduced NO production that occurs
by the competition for L-arginine and eNOS uncoupling.
Also, the authors highlighted that it is possible to prevent
or slow down the degenerative effect in muscle aging by lim-
iting arginase activity.
We hope that this special issue has been successful in pro-
viding new insights into the impact of oxidative stress in
muscle physiology and several muscle disorders. Editors con-
sidered the interdisciplinary nature of the papers included as
necessary to expand on fundamental concepts, i.e., basic
research as well as those important to applied sciences.
Therefore, the readers of this special issue should find infor-
mation of interest, relevant to their respective areas of scien-
tific investigations.
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